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Introduction: 99mTc-MAA (macroaggregates of albumin) is the selected radiopharmaceutical for 
the Lung Perfusion Scintigraphy. It is retained in lung capillaries by mechanical blockage 
resulting in local microembolization. Care should be taken concerning not only particle size but 
also the number of particles administered to patients, particularly those who present with 
special conditions (pulmonary hypertension, shunt or lung transplant). European 
Pharmacopoeia only requires the assessment of particle size. This work aims to characterize 
particle size and particle aggregation of two commercial brands of MAA kits and to compare 
particle counting methods. 
Material and Methods: Twenty kits of 99mTc-MAA from two distinct sources were labeled 
according to respective manufacturer’s instructions. Two aliquots of 1 ml from each kit were 
collected to pre-identified tubes. Particle counting was performed by at least three distinct 
observers using two distinct methods: the “empirical” (based on the relation between the total 
number of particles per vial and the correspondent administered volume) and the 
“experimental” (based on the hemocytometer determination). A “pool” of four independent 
observers was involved in the experimental approach, always using the same optical 
microscope and hemocytometer. Particle counting from each 1ml-aliquots was done in 
triplicate by each observer, resulting in 6 evaluations per observer/per kit, so 120 evaluations 
in total. Both methods were compared using linear regression to obtain the R2 value 
(correlation coefficient) while simultaneously accessing the inter-observer variability at the 
hemocytometer determination. Results were compared using Student-t test.  
 Results:  As an example of the already obtained results, it has been experimentally determined 
a mean number of particles of 1,05 millions/ml, to be compared with the correspondent value 
of 1,5 millions/ml empirically determined. Considering the inter-operator variability in the 
experimental calculation, it has been registered a variability superior to 5%. All samples 
complied with European Pharmacopoeia concerning particle size. No particles above 150 µm 
and no more than 0,2% of particles above 100 µm were observed.  
Discussion and Conclusion: Obtained results show that the number of particles calculated by 
different methods could vary, and that the operator’s intrinsic characteristics are important in 
the experimental determination. Empirical method is easier to perform, less time consuming 
and does not require special equipment.  On the other side, by choosing the experimental 
method, one has the opportunity to assess particle size simultaneously, as stated by the 
European Pharmacopoeia. 
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